Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Department of Error] Department of Error

Annane D, Fuchs-Buder T, Zoellner C, Kaukonen M, Scheeren TWL. EMA recommendation to suspend HES is hazardous. Lancet 2018; 391: 736–37—Although all authors provided competing interests statements prior to publication of this Correspondence, these details were not included in the published version. The online version of this Correspondence has been updated to include the competing interests statements for all authors as of March 8, 2018.